Roberta Cirsmaru/LinkedIn
Jul 8, 2026, 05:53
Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
CRH French Reference Center for Hemophilia Lyon shared a post on LinkedIn:
”Delighted to have served on the PhD defense committee of Roberta Cirsmaru, supervised by my friend Professor Follenzi.
Her thesis presented outstanding and innovative work in regenerative medicine, exploring the potential of ex vivo gene-modified BOECs for the treatment of hemophilia A.
Congratulations to Roberta on this excellent scientific achievement.
It was a pleasure to take part in such stimulating discussions on a field that continues to push the boundaries of translational medicine.”
Stay updated with Hemostasis Today.
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’
-
Jul 7, 2026, 20:59William Aird: An Unlucky Turn Into the Renal Artery